The proportions of mutations in each of the Lynch syndrome genes are MLH1 (40%), MSH2 (34%), MSH6 (18%), and PMS2 (2%), with the cancer risk varying depending on the gene involved. This evidence concerns the gene MSH2 and Lynch syndrome.